The KIST fellow system is a new system established last year. This KIST fellow system supports to those eminent scholars for their continuous outstanding research activities, who have already made global-leading accomplishments.
The KIST explained Dr. Kim was selected as a Fellow member because “Dr. In-San Kim is an extraordinarily eminent integrative medicine scholar in Korea. Recently, he also proved himself as a global leader through the achievements of research on drug development based on natural nanoparticles, Ferrtine, and Extracellular Vesicles (EVs). Additionally, EV-based new drug platform technology, which is Dr. In-San Kim’s main field of study, is a branch with endless potential to be developed and utilized as a rare disease treatment research in our future.”
You can reach out to the full content by clicking the links below.
The KIST fellow system is a new system established last year. This KIST fellow system supports to those eminent scholars for their continuous outstanding research activities, who have already made global-leading accomplishments.
The KIST explained Dr. Kim was selected as a Fellow member because “Dr. In-San Kim is an extraordinarily eminent integrative medicine scholar in Korea. Recently, he also proved himself as a global leader through the achievements of research on drug development based on natural nanoparticles, Ferrtine, and Extracellular Vesicles (EVs). Additionally, EV-based new drug platform technology, which is Dr. In-San Kim’s main field of study, is a branch with endless potential to be developed and utilized as a rare disease treatment research in our future.”
You can reach out to the full content by clicking the links below.
https://lnkd.in/gcSwdqnz
https://www.yna.co.kr/view/AKR20221101129700017?input=1195m
https://news.mt.co.kr/mtview.php?no=2022110117392528510
http://www.dt.co.kr/contents.html?article_no=2022110102109931731006&ref=naver
https://www.dongascience.com/news.php?idx=56916
https://biz.chosun.com/science-chosun/science/2022/11/01/IIIK4P7BYJDQPKIF4EMVBFC7LI/?utm_source=naver&utm_medium=original&utm_campaign=biz
https://www.newsworks.co.kr/news/articleView.html?idxno=613606
http://www.worktoday.co.kr/news/articleView.html?idxno=29819
http://news.heraldcorp.com/view.php?ud=20221101000575
http://www.ccnnews.co.kr/news/articleView.html?idxno=274456
https://www.hellodd.com/news/articleView.html?idxno=98522